Skip to main content
. 2021 Dec 27;39(1):89–103. doi: 10.1007/s11095-021-03158-x

Fig. 5.

Fig. 5

Influence of FcγRIIa-blocking on the cytotoxicity of ADC aggregates in MEG01-S cells. FcγRIIa on MEG01-S cells were blocked by using a Fab fragment of anti-FcγRIIa antibody (Fab-IV.3). MEG01-S cells were pre-treated with Fab-IV.3 (final concentration: 2 μg/mL) for 30 min, and then the serially diluted samples were added to the FcγRIIa-blocking MEG01-S cells. (a) The cellular uptake of Tra-FL aggregates under an FcγRIIa-blocking condition. The control cells, FcγRIIa-blocking cells, and cells under a low temperature condition were incubated with the serially diluted samples (control or aggregates; final concentration: 5, 13, 32, or 80 nM) for 4 h. The fluorescent intensities were measured by flow cytometer. The data represent the means ± standard deviation (n = 3). (b) The cytotoxicity of ADC aggregates under an FcγRIIa-blocking condition. The control cells and FcγRIIa-blocking cells were incubated with serially diluted samples (control, aggregates, or filtrated samples) for 3 days, and the cell proliferations were measured by wst-8 assay. The concentrations of filtered samples represent pre-filtration concentration of the samples. The data represent individual plots (n = 2).